Common challenges in obtaining accurate stage data include:

Common challenges in obtaining accurate stage data include:

• A. Too many doctors' notes
• B. Stage always matches across clinical and pathologic
• C. Absence of ICD-O codes
• D. Missing stage data

Answer: (D)

Stage information is essential for describing how far a cancer has spread at diagnosis, guiding prognosis, treatment decisions, and comparisons across patients and registries. When stage data are missing, analysts can’t accurately classify disease extent, which directly undermines data quality and can bias survival analyses and treatment outcome studies. That’s why missing stage data is the most widespread and impactful challenge in obtaining accurate stage information. Other scenarios are less central to stage accuracy. Having a lot of doctors’ notes isn’t by itself a specific barrier; the issue is whether the stage is documented in a usable, extractable way. The idea that stage always matches between clinical and pathologic assessments is incorrect—clinical stage (based on imaging and exam) and pathologic stage (based on surgical pathology) can differ, so discrepancies are common. ICD-O codes relate to tumor site and histology, not stage, so their absence affects histology/site coding rather than the completeness of stage data.

Stage information is essential for describing how far a cancer has spread at diagnosis, guiding prognosis, treatment decisions, and comparisons across patients and registries. When stage data are missing, analysts can’t accurately classify disease extent, which directly undermines data quality and can bias survival analyses and treatment outcome studies. That’s why missing stage data is the most widespread and impactful challenge in obtaining accurate stage information.

Other scenarios are less central to stage accuracy. Having a lot of doctors’ notes isn’t by itself a specific barrier; the issue is whether the stage is documented in a usable, extractable way. The idea that stage always matches between clinical and pathologic assessments is incorrect—clinical stage (based on imaging and exam) and pathologic stage (based on surgical pathology) can differ, so discrepancies are common. ICD-O codes relate to tumor site and histology, not stage, so their absence affects histology/site coding rather than the completeness of stage data.